TRIALS UPDATE: Our Q3 Roundup of Dementia Clinical Trials News
By
The Editors
| November 5th, 2024
This past three months in the Alzheimer’s drug development space have seen a new FDA approval for a symptomatic treatment, a couple failed phase…